Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-06-17

Insight Molecular Diagnostics (IMDX)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$2,594,786
Joshua Riggs total, FY2025
CEO pay percentile vs peers
CEO-to-median pay ratio
99.76%
Say-on-pay support, latest vote
Companies that benchmark against IMDX
1 company names IMDX as a compensation peer

Each company listed discloses IMDX in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named IMDX in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Joshua Riggs$472,293$184,675$599,999$1,332,000$0$0$5,819$2,594,786
President and Chief Executive Officer
Andrea James367,355152,293359,998782,5500016,9301,679,126
Chief Financial Officer
James Liu221,80468,31159,99791,7400013,138454,990
VP of Accounting, Controller, Treasurer & Principal Accounting Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Joshua Riggs$2,594,786$786,077+1,808,709
Andrea James1,679,126758,863+920,263
James Liu454,990303,928+151,062

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

No insider equity transactions reported since the proxy statement.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Andrea JamesOption125,0002.87
Andrea JamesRSU113,207359,998
James LiuOption6,0422.76
James LiuOption9519.26
Joshua RiggsOption3227.8
James LiuOption70217.74
Andrea JamesRSU50,000101,500
Andrea JamesOption235,0003.33
Joshua RiggsOption6,5564.26
James LiuOption10,0003.18
James LiuOption3,8883.11
Joshua RiggsOption400,0003.33
Joshua RiggsRSU188,679599,999
Joshua RiggsOption54,3752.76
James LiuRSU18,86759,997
James LiuOption18,0003.33
Joshua RiggsOption4,2919.26
Joshua RiggsOption44923.4
05

Incentive-plan design — the Compensation Discussion & Analysis

iMDx's executive compensation program is designed to attract, motivate and retain highly-qualified executive officers in a competitive market; provide compensation that is competitive and rewards the achievement of challenging business objectives; and align executive officers' interests with those of shareholders by providing a significant portion of total compensation in the form of equity awards.

CEO STI target (% of salary)50%
CEO LTI target (% of salary)
Independent consultantFrederic W. Cook & Co., Inc.
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-1119,199,69726,12619,67999.76%Passed
20252025-06-2718,063,63928,64712,01099.78%Passed
20222022-07-1536,805,24234,793,7661,188,06851.4%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-1199.76%a
20252025-06-2799.78%b
20222022-07-1551.4%c

a. Approved under the standard stated in the filing — “Abstentions will have the same effect as votes "against" this proposal.”.

b. Approved under the standard stated in the filing — “Abstentions will have the same effect as votes "against" this proposal.”.

c. Approved under the standard stated in the filing — “Broker non-votes and abstentions will not affect the outcome of any of the proposals to be voted upon.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)
CEO total compensation
Median employee compensation
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Andrew ArnoIndependent · Board Chair · Audit · Compensation · Nominating/Corporate Governance (Chair)$145,427$167,200$0$0$0$312,627
Andrew J. LastIndependent · Audit (Chair) · Compensation · Nominating/Corporate Governance85,427106,400000191,827
Louis E. SilvermanIndependent · Audit · Compensation (Chair) · Nominating/Corporate Governance85,427106,400000191,827
Joshua RiggsEmployee director00000
09

Board fee structure and ownership guideline

Annual cash retainer$85,427
Annual equity retainer
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$316,281
Equity awards (grant-date value)$380,000
All other compensation$0
Total cost of the board$696,281

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Insight Molecular Diagnostics2025Joshua Riggs$472,293$599,999$1,332,000$0$2,594,786

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Joshua RiggsDEF 14A2026-04-300001493152-26-020502Section “Summary Compensation Table” · page 15. As printed: 2,594,786. Filing ↗machine: span 319266–319275
2Section 01, Andrea JamesDEF 14A2026-04-300001493152-26-020502Section “Summary Compensation Table” · page 15. As printed: 1,679,126. Filing ↗machine: span 322463–322472
3Section 01, James LiuDEF 14A2026-04-300001493152-26-020502Section “Summary Compensation Table” · page 15. As printed: 454,990. Filing ↗machine: span 325630–325637
4Section 07, pay ratio10-K2026-03-260001642380-26-000004Section “CEO Pay Ratio”. As printed: —. Filing ↗
5Section 08, Andrew ArnoDEF 14A2026-04-300001493152-26-020502Section “Director Compensation”. As printed: 312,627. Filing ↗machine: t58 · r1 · c25 · span 292251–292258
6Section 08, Andrew J. LastDEF 14A2026-04-300001493152-26-020502Section “Director Compensation”. As printed: 191,827. Filing ↗machine: t58 · r2 · c25 · span 293244–293251
7Section 08, Louis E. SilvermanDEF 14A2026-04-300001493152-26-020502Section “Director Compensation”. As printed: 191,827. Filing ↗machine: t58 · r3 · c25 · span 294241–294248
8Section 08, Joshua RiggsDEF 14A2026-04-300001493152-26-020502Section “Director Compensation”. As printed: 0. Filing ↗
9Section 06, 2026 voteForm 8-K2026-06-170001493152-26-029078Item 5.07 · say-on-pay result. As reported: 99.76% (votes for as printed: 19,199,697). Filing ↗
10Section 06, 2025 voteForm 8-K2025-07-020001641172-25-017590Item 5.07 · say-on-pay result. As reported: 99.78% (votes for as printed: 18,063,639). Filing ↗
11Section 06, 2022 voteForm 8-K2022-07-210001493152-22-020023Item 5.07 · say-on-pay result. As reported: 51.4%. Filing ↗
12Section 01 trend, Δ column (computed)ComputedcomputedΔ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
13Section 09b board cost (computed)ComputedcomputedCash 316,281 + equity 380,000 + all other 0 = 696,281, summed across the director compensation table rows.machine: formula: Σ = 696,281
14Insight Molecular Diagnostics (subject), Section 10b CEO totalDEF 14A2026-04-300001493152-26-020502CEO total compensation as printed in Insight Molecular Diagnostics's own proxy. As printed: 2,594,786. Filing ↗machine: span 319266–319275